|
PRDM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.51952999999372E-05 |
| Normal-vs-Stage3 |
8.42659275690494E-14 |
| Normal-vs-Stage4 |
2.69339994751761E-09 |
| Stage1-vs-Stage2 |
5.166600E-01 |
| Stage1-vs-Stage3 |
1.997220E-01 |
| Stage1-vs-Stage4 |
1.203840E-01 |
| Stage2-vs-Stage3 |
8.274000E-01 |
| Stage2-vs-Stage4 |
6.663800E-01 |
| Stage3-vs-Stage4 |
7.655400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.05870000000063E-06 |
| Normal-vs-Asian |
7.06809999972968E-07 |
| Caucasian-vs-AfricanAmerican |
4.991000E-01 |
| Caucasian-vs-Asian |
4.300400E-01 |
| AfricanAmerican-vs-Asian |
2.608800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.2358781492926E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
3.673700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(61-80Yrs) |
1.210800348872E-10 |
| Normal-vs-Age(81-100Yrs) |
3.856300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.738600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.055100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.322800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.963600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.550120E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.515800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.796700E-03 |
| Classical-VS-Follicular |
1.199960E-02 |
| Classical-VS-Other |
2.528000E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
6.536400E-01 |
| Tall-VS-Other |
8.537400E-01 |
| Tall-VS-Normal |
1.31439999995209E-06 |
| Follicular-VS-Other |
7.507200E-01 |
| Follicular-VS-Normal |
2.39330000262328E-09 |
| Other-VS-Normal |
2.666500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
7.81150033546396E-10 |
| N0-vs-N1 |
8.301400E-01 |
|
|
